Maastricht Radiation Oncology
Clinical trials sponsored by Maastricht Radiation Oncology, explained in plain language.
-
Lab-Grown lung tumors could personalize cancer care
Knowledge-focused OngoingThis study collects extra tissue and a small blood sample from people undergoing standard procedures for lung cancer. Researchers will use these samples to grow miniature versions of the tumors, called organoids, in the lab. The goal is to study how lung cancers grow and change, …
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Brain scans may predict who faces memory loss after radiation
Knowledge-focused OngoingThis study is testing whether advanced MRI scans can predict which meningioma patients will experience cognitive decline after radiotherapy. Researchers will follow 67 patients for two years, using cognitive tests and brain imaging before and after treatment. The goal is to ident…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Lung cancer immune study aims to unlock biomarkers for better treatment
Knowledge-focused OngoingThis study looks at how the immune system changes in 45 people with stage III non-small cell lung cancer who receive chemoradiation followed by the drug durvalumab. Researchers want to find immune markers that could predict how well the treatment works. The goal is to improve fut…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC